Antengene Reports First Profit as Pipeline Advances
Shanghai and Hong Kong, PRC, August 24, 2026 Antengene Corporation Limited has reported its first-ever profitable period, alongside continued...
non-steroidal therapy
Advertisement
Henlius Reports 2026 Interim Results, Global Growth Advances
Shanghai, China,August 20, 2026 Henlius announced its 2026 interim results, highlighting continued financial growth, expanding global commercialization, and progress...
Evolved By Nature Peptide Platform Advances Atopic Dermatitis Care
Needham, Massachusetts, USA,August 20, 2026 Evolved By Nature, Inc. announced that its programmable peptide platform has been used in...
Devonian Begins Pediatric Phase II/III Thykamine Trial
QUÉBEC, Canada, July 21, 2026 Devonian Health Group has received Health Canada authorization to initiate a Phase II/III clinical...
Kiora Secures New U.S. Patent Expanding KIO-104 Formulation Options
Encinitas, California — December 1, 2025 — Kiora Pharmaceuticals has been granted a new U.S. patent (US-12,472,263) covering additional...
Advertisement
